Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biomarkers Discovered for Inflammatory Bowel Disease

Published: Thursday, May 23, 2013
Last Updated: Thursday, May 23, 2013
Bookmark and Share
Researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and intervention.

This finding, the first of its kind and led by UC’s Bruce Yacyshyn, MD, is being presented via podium presentation by staff from Walter Reed National Military Medical Center at Digestive Disease Week 2013, being held May 18-21 in Orlando, Fla.
 
The DoDSR is a biological repository operated by the U.S. Department of Defense and contains over 50 million human serum specimens, collected primarily from applicants to and members of the U.S. uniformed services.
 
"With collaborators from Walter Reed, we were able to identify all of the active duty service men and women who developed IBD and then used the repository to go back and look at various biomarkers to see what each person had in common,” says Yacyshyn, a professor of medicine at the UC College of Medicine and UC Health gastroenterologist.
 
IBD is a group of inflammatory conditions of the colon and small intestine. The main types of IBD are Crohn's disease and ulcerative colitis; inflammatory bowel diseases are considered autoimmune diseases in which the body's own immune system attacks elements of the digestive system.
 
In this study, researchers used the repository to identify 50 cases of Crohn’s disease and 50 cases of ulcerative colitis. They analyzed proteins from three samples per case—two taken before and one after diagnosis—using a statistical analysis format.
 
Certain proteins were found in elevated levels in samples from patients who developed IBD.
                                                                                                                                                              
"The selection of proteins we chose to analyze was based on a prior study conducted at UC,” Yacyshyn says. "Although the presence of proteins in those who develop Crohn’s disease varies from those present in ulcerative colitis patients, we were able to show that there were elevated levels of certain proteins in patients who developed IBD.”
 
"Future large validation studies are needed to confirm the presence of biomarkers to guide in diagnosis, prevention and management of these patients,” he adds.
 
Yacyshyn and his collaborators in the division of digestive diseases and at Cincinnati Children’s Hospital Medical Center are hoping to study this further in a pediatric population and have requested funding from the Crohn’s and Colitis Foundation.
 
"This could change the way we currently screen for and treat IBD, which could improve prevention strategies, patient outcomes and their overall quality of life,” he says.
 
This study was investigator-initiated.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

'Wimpy' Antibody Protects Against Kidney Disease in Mice
Study finds that the mouse antibody IgG1 may actually be protective.
Tuesday, November 04, 2014
Hello? Sweat and a Smartphone Could Become The Hot New Health Screening
A new article highlighting UC research reveals how sweat and microfluidics can pinpoint and help dodge potential health issues for everyone from athletes to preemies.
Tuesday, October 28, 2014
UC Develops Unique Nano Carrier to Target Drug Delivery to Cancer Cells
Researchers have developed a unique nanostructure that can, because of its dual-surface structure, serve as an improved “all-in-one tool” against cancer.
Thursday, October 31, 2013
Patient Openness to Research Can Depend on Race and Sex of Study Personnel
Researchers have found that the race and sex of study personnel can influence a patient’s decision on whether or not to participate in clinical research.
Monday, May 20, 2013
Researchers Solve Crystal Structure of Key Biofilm Protein
Scientists have solved the crystal structure of a protein involved in holding bacterial cells together in a biofilm, a major development in their exploration of the causes of hospital-acquired infections.
Monday, January 28, 2013
University of Cincinnati Announces Microfluidic Breakthroughs
Using something called “inertial microfluidics,” scientists are able to continuously and selectively collect rare cells, such as circulating tumor cells, based on their size vs. other biomarkers.
Wednesday, October 31, 2012
Researchers Discover Gene That Causes Deafness
University of Cincinnati scientists have found a new genetic mutation responsible for deafness and hearing loss associated with Usher syndrome type 1.
Wednesday, October 03, 2012
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!